Worldwide, consumers spend more than $80 billion per year chasing down various ways to regrow hair.
HCell Treatment is a safe, effective and convenient option for every pattern of hair loss; including
Hair loss in both genders shakes confidence to the very core, influencing life-altering decisions and choices in relationships, careers and leisure activities. According to a recent survey, nearly half of hair loss sufferers would drain their life savings to regain a full head of hair and even more would choose hair over promises of more money or friends—evidence that it’s traumatic to say goodbye to hair, or embarrassing at a minimum. HCell Treatment alleviates these types of burdensome worries when and if a person starts to lose hair—and, statistically, most of us eventually will.
Our process for reinstating hair growth is unmatched vis-à-vis our competitors with data showing average hair regrowth in treated areas across 100 percent (100%) of all patients. The most prolific regrowth appears in follicles that are in a “miniaturizing” stage, suffering a growth cycle disturbance, and not yet completely dead. Other methods can’t claim the same outcomes—this includes painful surgeries, messy creams and side effect-laden medications. Even traditional blood-based therapies on the market for more than a decade and newer offshoots incorporating animal by-products do not compare to HCell Treatment’s ability to revive and promote natural hair growth. HCell Treatment is a safe, convenient and, most significantly, an extremely effective solution to the problem of hair loss in today’s enormous global hair restoration industry. A recently completed independent university lab test in South Korea validates the congruent analysis of over 400 successfully treated patients since 2015.
Due to the proprietary and highly trade-secreted nature of HCell Treatment, we are protecting our intellectual assets with solid patent protection. Patents for other blood-based treatments do not exist, nor are they expected to be filed, as the technology has been open game in the marketplace for some time. However, HCell Treatment has been successfully patented—both patents, methodology and composition for hair growth, have already been granted in the United States and South Korea. Additionally, we have patents pending in Japan and with the Patent Cooperative Treaty covering 140 countries.